Is MOTS-c + BPC-157 too risky post-lymphoma?

Kyli

Explorer
Joined
Jun 12, 2026
Messages
86
Reaction score
0
Location
Bulgaria
Hi everyone,

Some input from you all would be appreciated. Hodgkin's lymphoma is what my mother had. It began 8-9 years ago and she went through hell - high-dose chemotherapy, radiation, a stem cell transplant, and more. Everything has been fine for 5 years. Lately though she's been feeling weaker, along with GI problems (a chemically damaged esophagus), kidney trouble and high blood pressure.

Since peptides gave me significant results, I suggested she look into some as well. MOTS-c and BPC-157 were on my shortlist for her. Her own research turned up a concern though: both may carry cancer-related risks, as they promote angiogenesis (new blood vessel growth).

Given that cancer history, it's a worry. What do you make of using these peptides in someone with a prior malignancy - any experience or opinions?
 
Back
Top